Abstract
A series of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential telomerase inhibitors were synthesized. The bioassay tests showed that compound 3b exhibited potentially high activity against human gastric cancer cell SGC-7901 with IC50 value was 2.98±0.16. Docking simulation was performed to position compound 3b into the telomerase (3DU6) active site to determine the probable binding model. The result shows that some coumarin containing 4,5-dihydropyrazole moiety can combine well with the telomerase active site and may have use as potential telomerase inhibitors.
Keywords: Coumarin, Dihydropyrazole, Molecular Docking, Antitumor Agent, Anticancer activity, Telomerase inhibitiors, Immortality, Ageing makes, Age-associated disorders, Human gastric cancer, Human liver cancer, Cytostatic properties, Cytotoxic activity, Mammalian cancer, Small bioactive molecule, CB1 antagonist, Docking simulation, Telomerase 3DU6, XT-4 binocular microscope, Pulse Fourier-transform NMR spectrometer, Analytical reagent-grade, Human gastric cell, Potent inhibitor, Telomerase, Binding mode, ATP binding site
Letters in Drug Design & Discovery
Title: Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-7-fluoro-2H-chromen-2-one Derivatives: Synthesis and Anticancer Activity
Volume: 7 Issue: 9
Author(s): Zheng-Yu Cai, Yang Yang, Xin-Hua Liu and Xing-Bao Qi
Affiliation:
Keywords: Coumarin, Dihydropyrazole, Molecular Docking, Antitumor Agent, Anticancer activity, Telomerase inhibitiors, Immortality, Ageing makes, Age-associated disorders, Human gastric cancer, Human liver cancer, Cytostatic properties, Cytotoxic activity, Mammalian cancer, Small bioactive molecule, CB1 antagonist, Docking simulation, Telomerase 3DU6, XT-4 binocular microscope, Pulse Fourier-transform NMR spectrometer, Analytical reagent-grade, Human gastric cell, Potent inhibitor, Telomerase, Binding mode, ATP binding site
Abstract: A series of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential telomerase inhibitors were synthesized. The bioassay tests showed that compound 3b exhibited potentially high activity against human gastric cancer cell SGC-7901 with IC50 value was 2.98±0.16. Docking simulation was performed to position compound 3b into the telomerase (3DU6) active site to determine the probable binding model. The result shows that some coumarin containing 4,5-dihydropyrazole moiety can combine well with the telomerase active site and may have use as potential telomerase inhibitors.
Export Options
About this article
Cite this article as:
Cai Zheng-Yu, Yang Yang, Liu Xin-Hua and Qi Xing-Bao, Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-7-fluoro-2H-chromen-2-one Derivatives: Synthesis and Anticancer Activity, Letters in Drug Design & Discovery 2010; 7 (9) . https://dx.doi.org/10.2174/157018010792929540
DOI https://dx.doi.org/10.2174/157018010792929540 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Are Bacteriocins Underexploited? NOVEL Applications for OLD Antimicrobials
Current Pharmaceutical Biotechnology The Role of Antiangiogenetic Agents in the Treatment of Breast Cancer
Current Medicinal Chemistry Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets Therapeutic Targeting of Cancers with Loss of PTEN Function
Current Drug Targets Studies on Chloride Channels and their Modulators
Current Topics in Medicinal Chemistry Functional Food: Product Development and Health Benefits
Recent Patents on Engineering Harmine Induces Gastric Cancer Cell Apoptosis through the ROSmediated PI3K/AKT Signaling Pathway
Current Signal Transduction Therapy Juglone Exerts Cytotoxic, Anti-proliferative and Anti-invasive Effects on Glioblastoma Multiforme in a Cell Culture Model
Anti-Cancer Agents in Medicinal Chemistry Characterization of Stem-Like Cells Directly Isolated from Freshly Resected Laryngeal Squamous Cell Carcinoma Specimens
Current Stem Cell Research & Therapy Optimization of Time Controlled 6-mercaptopurine Delivery for Site- Specific Targeting to Colon Diseases
Current Drug Delivery Microarray Technologies for Intracellular Kinome Analysis
Current Medicinal Chemistry Withdrawn: Mesenchymal Stem Cell-derived Exosomes for Treatment of Ischemic Stroke
Current Stem Cell Research & Therapy Targeting Membrane Transporters and Receptors as a mean to Optimize Orally Delivered Biotechnological based Drugs through Nanoparticle Delivery Systems
Current Pharmaceutical Biotechnology Adhesion Molecules as Targets for the Treatment of Neoplastic Diseases
Current Pharmaceutical Design Diagnosis and Management of Lynch Syndrome
Recent Patents on Regenerative Medicine Distribution, Bioactivities and Therapeutical Potentials of Pentagalloylglucopyranose
Current Bioactive Compounds The Oxido-reductase Activity of the Apoptosis Inducing Factor: A Promising Pharmacological Tool?
Current Pharmaceutical Design Synthesis and Anti-onchocercal Activity of Isonicotinoylhydrazones and their Copper(II) and Zinc(II) Complexes
Anti-Infective Agents Multifunctional Delivery Systems for Advanced oral Uptake of Peptide/Protein Drugs
Current Pharmaceutical Design Spectrum of Radiopharmaceuticals in Nuclear Oncology
Current Cancer Drug Targets